Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway

There were approximately 1.93 million new cases and 940 000 deaths from colorectal cancer in 2020. The first‐line chemotherapeutic drugs for colorectal cancer are mainly based on 5‐fluorouracil, although the use of these drugs is limited by the development of drug resistance. Consequently, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen, Sun, Ruiqian, Zhang, Yongjun, Hu, Rong, Li, Qian, Wu, Weili, Cao, Xinyu, Zhou, Jiajian, Pei, Jianfeng, Yuan, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564099/
https://www.ncbi.nlm.nih.gov/pubmed/34496154
http://dx.doi.org/10.1002/2211-5463.13290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564099/
https://www.ncbi.nlm.nih.gov/pubmed/34496154
http://dx.doi.org/10.1002/2211-5463.13290

Ejemplares similares